Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia
NCT ID: NCT00567671
Last Updated: 2010-09-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
160 participants
INTERVENTIONAL
2007-12-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corneal Crosslinking in Keratoconus and Corneal Ectasia
NCT00679666
Corneal Collagen Cross-Linking for Ectasia (CXL)
NCT00674661
Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light
NCT05027295
Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs
NCT01081561
Corneal Crosslinking in Patients With Keratoconus and Post-Refractive Ectasia
NCT01143389
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects may be referred from other physicians but must return to Emory Vision for completion of all study visits.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
Corneal collagen cross-linking
Corneal collagen
Corneal collagen cross-linking with riboflavin/UVA light
Control
Sham Treatment
Sham comparator
Sham treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Corneal collagen
Corneal collagen cross-linking with riboflavin/UVA light
Sham comparator
Sham treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of corneal ectasia
* Must be able to complete all study visits
Exclusion Criteria
* Corneal scarring
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Woolfson Eye Intitute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
R. Doyle Stulting, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Emory Vision; Emory University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Woolfson Eye Institute
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hallahan KM, Rocha K, Roy AS, Randleman JB, Stulting RD, Dupps WJ Jr. Effects of corneal cross-linking on ocular response analyzer waveform-derived variables in keratoconus and postrefractive surgery ectasia. Eye Contact Lens. 2014 Nov;40(6):339-44. doi: 10.1097/ICL.0000000000000090.
Related Links
Access external resources that provide additional context or updates about the study.
Click here to contact the investigator site for this study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UVX-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.